510(k) Report

510(k) · Cleared

Cleared

Psychemedics Microplate Eia for Oxycodone in Hair

K123799510(k) TraditionalCleared Feb 8, 201360-day reviewClass II21 CFR 862.3650

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Psychemedics Corp. · DJG Enzyme Immunoassay, Opiates

Cleared on Feb 8, 2013 as substantially equivalent to K014101 (American Bio Medica Corp., 2002) after a 60-day review. Its family tree reaches back 1 generation to 2002. 1 later device descends from it.

Decided
Feb 8, 2013
Review
60 days
Class
Class II
Product code
DJG
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K014101 (2002). 1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2021: 1 descendant clearedK014101 · Rapidone-Oxy Test · American Bio Medica Corp. · 2002200020052010201520202025
Descendants, by generation 1 generation forward: 1 descendant K014101 · Rapidone-Oxy Test · American Bio Medica Corp. · 20020
  1. Root · 1 generation backK014101 Rapidone-Oxy TestAmerican Bio Medica Corp. · 2002
  2. This deviceK123799 Psychemedics Microplate Eia for Oxycodone in HairPsychemedics Corp. · 2013
  3. Descendant · cites it directly · 0 of its ownK201326 Psychemedics Homogeneous Enzyme Immunoassay (HEIA) for Opiates in…Psychemedics Corporation · 2021

Most influential descendants

Showing 1 of 1 · See all
  • K201326Psychemedics Homogeneous Enzyme Immunoassay (HEIA) for Opiates in Hair, Psychemedics…Psychemedics Corporation · 2021 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K014101Rapidone-Oxy TestAmerican Bio Medica Corp.2002—
0 (this device)K123799Psychemedics Microplate Eia for Oxycodone in HairPsychemedics Corp.2013—
+1K201326Psychemedics Homogeneous Enzyme Immunoassay (HEIA) for Opiates in Hair…Psychemedics Corporation2021—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202110
FIG. 1 — Lineage of K123799, 2002–2021Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DJG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DJG device

  1. #1 K232659 Dochek® Multi-Drug Urine Test Cup Rx, Dochek®…score 17.6 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K014101Rapidone-Oxy Test
Summary page 1
…December 7, 2012 Device-Trade Name: Psychemnedics Microplate FIA for Oxycodone in Hair Predicate Device: RapidOne-OXY Test, k014101 Product Code: DJG DeviceClassification/Name: 21 CER 862.3650, Enzyme Immunoiassay, Opiates;…
American Bio Medica Corp.2002—

Also cleared against K014101: 2 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K201326Psychemedics Homogeneous Enzyme Immunoassay (HEIA) for Opiates in Hair, Psychemedics…Psychemedics Corporation20210

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K201326 (Psychemedics Corporation, 2021) has gone furthest, with 0 descendants of its own.
  • 2 other devices also cite its predicate K014101.

How does its category compare?

All DJG devices

DJG Enzyme Immunoassay, Opiates: FDA decisions, review times, recalls and adverse event reports over 20 years. 2013, this device’s year, is highlighted.

FDA decisions per year · DJG

3in 2025

2007: 22008: 22009: 22010: 62011: 62012: 52013: 52014: 92015: 122016: 22017: 42018: 52019: 32020: 52021: 32022: 22023: 102024: 52025: 32026 (partial year): 3
2007high 12 (2015) · low 2 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DJG

31in 2025

2010: 187 days median2011: 233 days median2012: 95 days median2013: 60 days median2014: 62 days median2015: 141 days median2017: 101 days median2018: 134 days median2019: 235 days median2020: 30 days median2021: 422 days median2023: 140 days median2024: 150 days median2025: 31 days median2026 (partial year): 157 days median
2007high 422 (2021) · low 30 (2020)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DJG

2in 2025

2011: 12019: 12025: 2
2007high 2 (2025) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DJG

1in 2025

2011: 42012: 12013: 42015: 32016: 22017: 12018: 12021: 22022: 12024: 32025: 1
2007high 4 (2011) · low 0 (2007)2025

MAUDE reports naming product code DJG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20082—00
20092—00
2010618700
2011623314
201259501
201356004
201496200
20151214103
20162—02
2017410101
2018513401
2019323510
202053000
2021342202
20222—01
20231014000
2024515003
202533121
202631570—

What is it indicated for?

The Psychemnedics Microplate EIA for Oxycodone is an enzyme immunoassay (EIA) for the preliminary qualitative detection of oxycodone in human head and body hair using a oxycodone calibrator at 2 ng /10 mg hair cutoff for the purpose of identifying oxycodone use. This is an in vitro diagnostic device intended exclusively for Psychemnedics use only and is not intended for sale to anyone. The Psychemnedics Microplate ETA oxycodone assay provides only a…

Read the full statement (150 words)

The Psychemnedics Microplate EIA for Oxycodone is an enzyme immunoassay (EIA) for the preliminary qualitative detection of oxycodone in human head and body hair using a oxycodone calibrator at 2 ng /10 mg hair cutoff for the purpose of identifying oxycodone use. This is an in vitro diagnostic device intended exclusively for Psychemnedics use only and is not intended for sale to anyone.

The Psychemnedics Microplate ETA oxycodone assay provides only a preliminary analytical test result. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. Gas or Liquid Chromatography/Mass Spectrometry (GC/MS or LC/MS or LC/MS/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary result is positive.

Psychemedics plans to perform this test at one site. Psychemnedics has not performed an evaluation of reproducibility at different sites.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K123799: Psychemedics Microplate Eia for Oxycodone in Hair.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K123799

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026